Channel:  SeroNet

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

57 Articles

A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies
Dinnon, K. H., Leist, S. R., Okuda, K., Dang, H., Fritch, E. J., Gully, K. L., Cruz, G., Evangelista, M. D., Asakura, T., Gilmore, R. C., Hawkins, P., Nakano, S., West, A., Schäfer, A., Gralinski, L. E., Everman, J. L., Sajuthi, S. P., Zweigart, M. R., Dong, S., McBride, J., Cooley, M. R., Hines, J. B., Love, M. K., Groshong, S. D., VanSchoiack, A., Phelan, S. J., Liang, Y., Hether, T., Leon, M., Zumwalt, R. E., Barton, L. M., Duval, E. J., Mukhopadhyay, S., Stroberg, E., Borczuk, A., Thorne, L. B., Sakthivel, M. K., Lee, Y. Z., Hagood, J. S., Mock, J. R., Seibold, M. A., O'Neal, W. K., Montg
10.1101/2022.02.15.480515 — Posted: 2022-02-15
Comparable Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
Yu, J., Collier, A.-r., Rowe, M., Mardas, F., Ventura, J., Wan, H., Miller, J., Powers, O., Chung, B., Siamatu, M., Hachmann, N., Surve, N., Nampanya, F., Chandrashekar, A., Barouch, D. H.
10.1101/2022.02.06.22270533 — Posted: 2022-02-07
Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques
Chandrashekar, A., Yu, J., McMahan, K., Jacob-Dolan, C., Liu, J., He, X., Hope, D., Anioke, T., Barrett, J., Chung, B., Hachmann, N., Lifton, M., Miller, J., Powers, O., Sciacca, M., Sellers, D., Siamatu, M., Surve, N., VanWyk, H., Wan, H., Wu, C., Pessaint, L., Valentin, D., Van Ry, A., Muench, J., Boursiquot, M., Cook, A., Velasco, J., Teow, E., Boon, A., Suthar, M., Jain, N., Martinot, A. J., Lewis, M. G., Andersen, H., Barouch, D. H.
10.1101/2022.02.06.479285 — Posted: 2022-02-07
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type virus and Delta variant
Jiang, L., Driedonks, T., Lowman, M., Jong, W. S., van den Berg van Saparoea, H. B., Dhakal, S., Zhou, R., Caputo, C., Littlefield, K., Sitaras, I., Chen, M. W., Lima, G., Gololobova, O., Smith, B., Mahairaki, V., Richardson, M. R., Mulka, K. R., Lane, A. P., Klein, S. L., Pekosz, A., Brayton, C. F., Mankowski, J. L., Luirink, J., Villano, J. S., Witwer, K. W.
10.1101/2021.06.28.450181 — Posted: 2022-02-01
Comprehensive antibody profiling of mRNA vaccination in children
Bartsch, Y. C., St Denis, K. J., Kaplonek, P., Kang, J., Lam, E. C., Burns, M. D., Farkas, E. J., Davis, J., Boribong, B., Edlow, A. G., Fasano, A., Shreffler, W., Zavadska, D., Johnson, M., Goldblatt, D., Balazs, A. B., Yonker, L. M., Galit, A.
10.1101/2021.10.07.463592 — Posted: 2022-01-04
Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant
Liu, J., Chandrashekar, A., Sellers, D., Barrett, J., Lifton, M., McMahan, K., Sciacca, M., VanWyk, H., Wu, C., Yu, J., Collier, A.-r., Barouch, D. H.
10.1101/2022.01.02.22268634 — Posted: 2022-01-03
Neutralization and Stability of SARS-CoV-2 Omicron Variant
Cong, Z., Evans, J. P., Qu, P., Faraone, J., Zheng, Y.-M., Carlin, C., Bednash, J. S., Zhou, T., Lozanski, G., Mallampalli, R., Saif, L. J., Oltz, E. M., Mohler, P., Xu, K., Gumina, R. J., Liu, S.-L.
10.1101/2021.12.16.472934 — Posted: 2021-12-20
Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization
Doria-Rose, N., Shen, X., Schmidt, S. D., O'Dell, S., McDanal, C., Feng, W., Tong, J., Eaton, A., Maglinao, M., Tang, H., Manning, K. E., Edara, V.-V., Lai, L., Ellis, M., Moore, K., Floyd, K., Foster, S. L., Atmar, R. L., Lyke, K. E., Zhou, T., Wang, L., Zhang, y., Gaudinski, M. R., Black, W. P., Gordon, I., Guech, M., Ledgerwood, J. E., Misasi, J. N., Widge, A., Roberts, P. C., Beigel, J., Korber, B., Pajon, R., Mascola, J. R., Suthar, M. S., Montefiori, D. C.
10.1101/2021.12.15.21267805 — Posted: 2021-12-20
The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders
Li, D., Xu, A., Mengesha, E., Elyanow, R., Gittelman, R. M., Chapman, H., Prostko, J. C., Frias, E. C., Stewart, J. L., Pozdnyakova, V., Debbas, P., Muzukian, A., Horizon, A. A., Merin, N., Joung, S., Botwin, G. J., Sobhani, K., Figueiredo, J. C., Cheng, S., Kaplan, I. M., McGovern, D. P. B., Merchant, A., Melmed, G. Y., Braun, J.
10.1101/2021.12.08.21267444 — Posted: 2021-12-08
Significantly elevated antibody levels and neutralization titers in nursing home residents after SARS-CoV-2 BNT162b2 mRNA booster vaccination
Canaday, D. H., Oyebanji, O. A., White, E. M., Keresztesy, D., Payne, M., Wilk, D., Carias, L., Aung, H., St. Denis, K., Sheehan, M. L., Berry, S. D., Cameron, C. M., Cameron, M. J., Wilson, B. M., Balazs, A. B., King, C. L., Gravenstein, S.
10.1101/2021.12.07.21267179 — Posted: 2021-12-07

RSS  Channel RSS